Splenic marginal zone B-cell and thymic T-cell lymphomas in p53- deficient mice

Laboratory Investigation

Volumn 79, Issue 1, 1999, Pages 3-14

  Ward, Jerrold M ^a   Tadesse Heath, Lekidelu ^b   Perkins, Susan N ^a   Chattopadhyay, Sisir K ^b   Hursting, Stephen D ^c   Morse III, Herbert C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; PROTEIN P53; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SPLEEN; T CELL LYMPHOMA; THYMUS;

ANIMALS; GENE DELETION; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; SPLEEN; THYMUS GLAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032944887     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Baldini L, Guffanti A, Cro L Fracchiolia NS, Colombi M, Motta M, Maiolo AT, and Neri A (1997). Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations. Br J Haematol 99:375-378.
2. Baldini L, Fracchiolia, Cro LM, Trecca D, Romitti L, Polli E, Maiolo AT, and Neri A (1994). Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin. Blood 84:270-278.
3. + low-grade marginal zone B-cell lymphomas with localized presentation. Am J Surg Pathol 22:201-207.
4. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, and Wynshaw-Boris A (1996). Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86:159-171.
5. + T cells. Curr Opin Immunol 7:367-374.
6. Chan JKC, Banks PM, Cleary ML, Delsol G, DeWolf-Peeters C, Falini B, Gatter KC, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Stein H, and Warnke RA (1994). A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology 25:517-536.
7. Chen X, Martin F, Forbush KA, Perlmutter RM, and Kearney JF (1997). Evidence for selection of a population of multireactive B cells into the splenic marginal zone. Int Immunol 9:27-41.
8. Della Porta G, Chieco-Biachi L, and Pennselli N (1979). Tumours of the haematopoietic system. In: Turusov VS, editor. Pathology of tumours in laboratory animals: Vol. 2 - Tumours of the mouse. Lyon: International Agency for Research on Cancer, 527-576.
9. DeWolf-Peeters C, Pittaluga S, Dierlamm J, Wlodarska I, and Van Den Berghe H (1997). Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone. Leuk Lymphoma 26:467-478.
10. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA Jr, Park SH, Thompson T, Ford RJ, and Bradley A (1995). Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog 14:16-22.
11. Dubus P, Vergier B, Beylot-Barry M, Delaunay MM, Goussot JF, Beylot C, de Mascarel A, Farcet JP, and Merlio JP (1996). Contribution of histopathologic and molecular analyses to the diagnosis of cutaneous B-cell infiltrates. Mod Pathol 9:1147-1155.
12. Dunn SE, Kari FW, French J, Leininger JR, Travlos, G, Wilson R, and Barrett JC (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667-4672.
13. Dunnick JK, Hardisty JF, Herbert RA, Seely JC, Furedi-Machacek EM, Foley JF, Lacks GD, Stasiewicz S, and French JE (1997). Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (±) mice. Toxicol Pathol 25:533-540.
14. Dunn-Walters DK, Boursier L, Spencer J, and Isaacson PG (1998). Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation. Hum Pathol 29:585-593.
15. Fredrickson TN, Morse HC III, Yetter RA, Rowe WP, Hartley JW, and Pattengale PK (1985). Multiparameter analyses of spontaneous nonthymic lymphomas occurring in NFS/N mice congenic for ecotropic murine leukemia viruses. Am J Pathol 121:349-360.
16. Fredrickson TN, Tang Y, Chattopadhyay SK, Morse HC III, and Hartley JW (1993a). Retrovirus-induced lymphoproliferation as a model for developing diagnostic criteria for malignant lymphoma in mice. Toxicol Pathol 21:219-228.
17. Fredrickson TN, Hartley JW, and Morse HC III (1993b). Early divergence of erythroid lineage suggested by gene rearrangements in mouse hematopoietic neoplasms. Exp Hematol 21:354-357.
18. Fredrickson TN, Hartley JW, Morse HC III, Chattopadhyay SK, and Lennert K (1995). Classification of mouse lymphomas. Curr Top Microbiol Immunol 194:109-116.
19. Fredrickson TN, Lennert K, Chattopadhyay SK, Morse III HC, and Hartley JW (in press 1999). Splenic marginal zone lymphomas in mice. Am J Pathol.
20. Frith CH, Ward JM, and Chandra M (1993). The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol Pathol 21:206-218.
21. Frith CH, Ward JM, Fredrickson T, and Harleman JH (1996). Neoplastic Lesions of the Hematopoietic System. In: Mohr U, Dungworth DL, Capen CC, Carlton. WW, Sundberg JP, and Ward JM, editors. Pathobiology of the aging mouse. Washington, DC: ILSI Press, 219-235.
22. Groeneveld PH, Erich T, and Kraal G (1985). In vivo effects of LPS on B lymphocyte subpopulations: Migration of marginal zone-lymphocytes and IgD-blast formation in the mouse spleen. Immunobiology 170:402-411.
23. Gross-Bellard M, Oudet P, and Chambon P (1973). Isolation of high molecular weight DNA from mammalian cells. Eur J Biochem 36:32-37.
24. Harvey M, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A, and Donehower LA (1993). Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet 5:225-229.
25. Harvey M, Vogel H, Morris D, Bradley A, Bernstein A, and Donehower LA (1995). A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nature Genet 9:305-311.
26. Hedrick SM, Germain RN, Bevan MJ, Dorf M, Engel I, Fink P, Gascoigne N, Heber-Katz E, Kapp J, Kaufmann Y, Kaye J, Melchers F, Pierce C, Schwartz R, Sorenson C, Taniguchi M, and Davis MM (1980). Rearrangement and transcription of a T-cell receptor β-chain gene in different congenic mice. Proc Natl Acad Sci USA 77:4871-4874.
27. Holmes KL, Lantz LM, Lee JS, Bedigian HG, and Taubenberger JK (1995). Characterization of a new antigen expressed by B and myeloid lineage cells identified by the monoclonal antibody LIP-6. Cell Immunol 166:131-140.
28. Hursting SD, Perkins SN, and Phang JM (1994). Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc Natl Acad Sci USA 91:7036-7040.
29. Hursting SD, Perkins SN, Haines DC, Ward JM, and Phang JM (1995). Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res 55:3949-3953.
30. Hursting SD, Perkins SN, Brown CC, Haines DC, and Phang JM (1997). Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deficient and wild-type mice. Cancer Res 57:2843-2846.
31. Jhappan C, Morse HC III, Fleischmann RD, Gottesman MM, and Merlino G (1997). DNA-PKcs: A T-cell tumour suppressor encoded at the mouse scid locus. Nature Genet 17:483-486.
32. Jones TC, Ward JM, Mohr U, and Hunt RD (1990). Monographs on pathology of laboratory animals: Hemopoietic system. Berlin: Springer-Verlag.
33. Kinzler KW and Vogelstein B (1997). Gatekeepers and caretakers. Nature 386:761-762.
34. Kleihues P, Schauble B, zur Hausen A, Esteve J, and Ohgaki H (1997). Tumors associated with p53 germline mutations: A synopsis of 91 families. Am J Pathol 150:1-13.
35. Kossakowska AE, Eyton-Jones S, and Urbanski SJ (1993). Immunoglobulin and T-cell receptor gene rearrangements in lesions of mucosa-associated lymphoid tissue. Diagn Mol Pathol 4:233-240.
36. Lang RB, Stanton LW, and Marcu KB (1982). On immunoglobulin heavy chain switching: Two γ2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed. Nucleic Acids Res 10:611-630.
37. Liao MJ, Zhang XX, Hill R, Gao J, Qumsiyeh MB, Nichols W, and Van Dyke T (1998). No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol Cell Biol 18:3495-3501.
38. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, and Jacks T (1995). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935-944.
39. Mao JH, Lindsay KA, Balmain A, and Wheldon TE (1998). Stochastic modelling of tumorigenesis in p53 deficient mice. Br J Cancer 77:243-252.
40. Marti GE, Metcalf RA, and Raveche E (1995). The natural history of a lymphoproliferative disorder in aged NZB mice. Curr Top Microbiol Immunol 194:117-126.
41. Mollejo M, Lloret E, Menarguez J, Piris MA, and Isaacson PG (1997). Lymph node involvement by splenic marginal zone lymphoma: Morphological and immunohistochemical features. Am J Surg Pathol 21:772-80.
42. Murakami H, Irisawa H, Saitoh T, Matsushima T, Tamura J, Sawamura M, Karasawa M, Hosomura Y and Kojima M (1997). Immunological abnormalities in splenic marginal zone cell lymphoma. Am J Hematol 56:173-8.
43. Nacht M and Jacks T (1998). V(D)J recombination is not required for the development of lymphoma in p53-deficient mice. Cell Growth Differ 9:131-138.
44. Oliver AM, Martin F, Gartland GL, Carter RH, and Kearney JF (1997). Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 27:2366-2374.
45. Pattengale PK (1994). Tumours of the lymphohaematopoietic system. In:Turusov VS and Mohr U, editors. Pathology of tumours in laboratory animals. 2nd ed., vol. 2. Lyon: International Agency for Research in Cancer, 651-670.
46. Pawade J, Wilkins BS, and Wright DH (1995). Low-grade B-cell lymphomas of the splenic marginal zone: A clinicopathological and immunohistochemical study of 14 cases. Histopathology 27:129-37.
47. Perkins SN, Hursting SD, Haines DC, James SJ, Miller BJ, and Phang JM (1997). Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16α-fluoro-5-androsten-17-one. Carcinogenesis 18:989-994.
48. Roark JH, Park SH, Jayawardena J, Kavita U, Shannon M, Bendelac A (1998). CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 160:3121-3127.
49. Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, Maloisel F, Clauvel JP, Brouet JC, and Mariette X (1997). Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 90:766-775.
50. Snapper CM, Yamada H, Smoot D, Sneed R, Lees A, and Mond JJ (1993). Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol 150:2737-2745.
51. Tennant RW, Spalding J, and French JE (1996). Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat Res 365:119-127.
52. Tierens A, Delabie J, Pittaluga S, Driessen A, and DeWolf-Peeters C (1998). Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 91:2381-2386.
53. Torlakovic E, Cherwitz DL, Jessurun J, Scholes J, and McGlennen R (1997). B-cell gene rearrangement in benign and malignant lymphoid proliferations of mucosa-associated lymphoid tissue and lymph nodes. Hum Pathol 28:166-173.
54. Wang TTY, Hursting SD, Perkins SN, and Phang JM (1997). Effects of dehydroepiandrosterone and calorie restriction on the Bcl-2/Bax-mediated apoptotic pathway in p53-deficient mice. Cancer Letts 116:61-69.
55. Wu CD, Jackson CL, and Medeiros LJ (1996). Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases. Am J Clin Pathol 105:277-285.
56. Yumoto T, Yoshida Y, Yoshida H, Ando K, and Matsui K (1980). Prelymphomatous and lymphomatous changes in splenomegaly of New Zealand black mice. Acta Pathol Jpn 30:171-186.